Delisting risk
AIDX · NASDAQ · Medical - Care Facilities

20/20 Biolabs

Blood testing for cancer screening and inflammation tracking, plus laboratory services for diagnostic developers.

$0.6332
After-hours close+0.00 (+0.54%)
At close$0.6298(+1.63%)
DateEstimateReportedSurprise
Aug 2026−$0.12−$0.26−116.7%
Aug 2026−$0.12−$0.26−116.7%
May 2026−$0.10−$0.28−180.0%
Mar 2026−$0.25
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Aug 17, 2026−$0.12−$0.26−116.7%$636.0K$730.6K+14.9%
Aug 14, 2026−$0.12−$0.26−116.7%$636.0K$730.6K+14.9%
May 20, 2026−$0.10−$0.28−180.0%$779.0K$353.4K−54.6%
Mar 31, 2026−$0.25$538.0K